Cell therapy company Vor Biopharma raises $176.9m for IPO
Vor Biopharma, a cell therapy company, has raised about $176.9 million for its IPO after pricing its over 9.8 million shares at $18 per share.
5 February 2021•3 mins read
Vor Biopharma, a cell therapy company, has raised about $176.9 million for its IPO after pricing its over 9.8 million shares at $18 per share.
